Allarity Therapeutics, Inc.
ALLR
$1.28
$0.032.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -23.82% | 18.47% | -20.21% | -20.95% | 15.08% |
| Total Depreciation and Amortization | 230.77% | -425.00% | 118.18% | -466.67% | 9.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 371.09% | -81.93% | 453.52% | 3.64% | 34.24% |
| Change in Net Operating Assets | 79.78% | -52.36% | -58.70% | 76.14% | -2,195.30% |
| Cash from Operations | 42.93% | -38.54% | 4.90% | 37.79% | -104.06% |
| Capital Expenditure | 100.00% | -700.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -700.00% | -- | -- | -- |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -99.18% | -90.04% | -- | -100.00% |
| Repurchase of Common Stock | 100.00% | 45.87% | -243.26% | 94.50% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | 8,325.00% | -110.39% | 190.06% | -123.02% |
| Foreign Exchange rate Adjustments | -360.34% | -104.52% | 560.82% | 110.45% | -549.30% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -118.72% | 785.01% | -143.71% | 90.85% | -221.20% |